Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CTX.WAthis companyCaptor Therapeutics Spolka Akcyjna	PLN 53.20	-9.46×	16.92×	85.26×	-7.99×	-150.3%	-14.0%	-1141.8%	-901.2%	-178.9%	-195.8%	-9.2%	0.15×	0.15×	-188.01×	2.27×	0.0%	2	7.35	1	C-
BIO.WABioton S.a.	PLN 3.49	97.72×	0.56×	1.17×	7.42×	-205.5%	34.2%	4.5%	1.2%	0.6%	0.8%	0.7%	0.1×	0.95×	2.19×	1.41×	0.0%	4	-0.67	3	B
CLN.WACelon Pharma S.A.	PLN 16.30	-13.84×	3.02×	5.22×	-104.55×	-150.2%	-18.8%	-27.1%	-37.8%	-21.8%	-14.1%	-2.8%	0.05×	0.04×	-35.54×	1.62×	0.0%	4	2.7	3	B+
MAB.WAMabion S.A.	PLN 7.72	-1.8×	2.31×	7.16×	-2.73×	-128.9%	-110.5%	-334.8%	-397.4%	-128.2%	-77.5%	-37.7%	0.26×	-0.14×	-65.62×	0.29×	0.0%	4	-3.73	1	D+
MOC.WAMolecure S.A.	PLN 5.45	-8.57×	1.54×	0×	-6.52×	-90.8%	0.0%	0.0%	0.0%	-17.9%	-23.7%	-14.4%	0.06×	0.58×	-286.48×	4.79×	0.0%	0	8.94	2	C+
NNG.WANanoGroup S.A.	PLN 2.25	-9.14×	10.01×	0×	-6.95×	-79.2%	0.0%	0.0%	0.0%	-108.7%	-52.0%	-11.5%	0×	1.5×	0×	0.79×	0.0%	2	73.43	1	C-
Peer median	—	-8.57×	2.31×	1.17×	-6.52×	-128.9%	0.0%	0.0%	0.0%	-21.8%	-23.7%	-11.5%	0.06×	0.58×	-35.54×	1.41×	0.0%	4	2.7	2	—